May 16 |
CNS Pharmaceuticals reports Q1 results
|
May 16 |
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 9 |
CNS Pharmaceuticals files for $75M mixed shelf offering
|
Apr 23 |
CNS Pharmaceuticals to Present at the LSX World Congress 2024
|
Apr 22 |
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
|
Apr 1 |
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
|
Apr 1 |
CNS Pharmaceuticals to Present at Two Investor Conferences in April
|
Feb 9 |
Top 5 Health Care Stocks That Are Preparing To Pump In February
|
Jan 30 |
CNS Pharmaceuticals prices $4M public offering
|
Jan 30 |
CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
|